×

TETRACYCLIC INHIBITORS OF JANUS KINASES

  • US 20090215766A1
  • Filed: 08/06/2008
  • Published: 08/27/2009
  • Est. Priority Date: 04/28/2004
  • Status: Abandoned Application
First Claim
Patent Images

1. A compound of Formula I:

  • or pharmaceutically acceptable salt or prodrug thereof, wherein;

    D1 is N, NO, or CR1a;

    D2 is N, NO, or CR1b;

    D3 is N, NO, or CR1c;

    D4 is N, NO or CR1d;

    Ring A is X and Y are each, independently, N or CR5;

    Z1 and Z2 are each, independently, N, CR6, or NO;

    wherein at least one of Z1 and Z2 is other than CR6;

    Ring B is D is O, S, or NR8;

    E is N or CR9;

    G is O, S, or NR8;

    J is N or CR7;

    R is —

    W1

    W2

    W3

    W4;

    W1 is absent, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, O, S, NR11, CO, COO, CONR11, SO, SO2, SONR11, SO2NR11, or NR11CONR12, wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl are each optionally substituted by 1, 2 or 3 halo, OH, C1-4 alkoxy, C1-4 haloalkoxy, amino, C1-4 alkylamino or C2-8 dialkylamino;

    W2 is absent, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, cycloalkyl, heteroaryl or heterocycloalkyl, wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, cycloalkyl, heteroaryl or heterocycloalkyl is optionally substituted by one or more halo, CN, NO2, OH, ═

    NH, ═

    NOH, ═

    NO—

    (C1-4 alkyl), C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, amino, C1-4 alkylamino or C2-8 dialkylamino;

    W3 is absent, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, O, S, NR10, ═

    N—

    , ═

    N—

    O—

    , ═

    N—

    O—

    (C1-4 alkyl), O—

    (C1-4 alkyl), S—

    (C1-4 alkyl), NR10

    (C1-4 alkyl), (C1-4 alkyl)-O—

    (C1-4 alkyl), (C1-4 alkyl)-S—

    (C1-4 alkyl), (C1-4 alkyl)-NR10

    (C1-4 alkyl), CO, COO, C(O)—

    (C1-4 alkyl), C(O)O—

    (C1-4 alkyl), C(O)—

    (C1-4 alkyl)-C(O), NR10C(O)—

    (C1-4 alkyl), C(O)NR10

    (C1-4 alkyl), NR10C(O)O—

    (C1-4 alkyl), NR10C(O)O, CONR10, SO, SO2, SONR10, SO2NR10, or NR10CONR11, wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl are each optionally substituted by 1, 2 or 3 halo, OH, CN, C1-4 alkoxy, C1-4 haloalkoxy, amino, C1-4 alkylamino or C2-8 dialkylamino;

    W4 is H, NR10R11, CN, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, cycloalkyl, heteroaryl or heterocycloalkyl, wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, cycloalkyl, heteroaryl or heterocycloalkyl is optionally substituted by 1, 2, 3, 4 or 5 halo, OH, CN, C1-4 alkoxy, ═

    NH, ═

    NOH, ═

    NO—

    (C1-4 alkyl), C1-4 haloalkyl, C1-4 haloalkoxy, COOH, COO—

    (C1-4 alkyl), amino, C1-4 alkylamino or C2-8 dialkylamino;

    R1a, R1b, R1c and R1d are each, independently, H, halo, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-4 haloalkyl, OH, C1-4 alkoxy, C1-4 haloalkoxy, CN, NO2, C(O)—

    (C1-4 alkyl), C(O)OH, C(O)O—

    (C1-4 alkyl), C(O)NH2, C(O)NH(C1-4 alkyl), C(O)N(C1-4 alkyl)2, S(O)2NH2, S(O)2NH(C1-4 alkyl), S(O)2N(C1-4 alkyl)2, S(O)2

    (C1-4 alkyl), NH2, NH(C1-4 alkyl), or N(C1-4 alkyl)2;

    R2 is H, OH, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl, heterocyclyl, carbocyclylalkyl or heterocyclylalkyl;

    R2a is C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, cycloalkyl, cycloalkylalkyl, heterocycloalkyl or heterocycloalkylalkyl;

    R3, R4, R5, and R6 are each, independently, H, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, halo, C1-4 haloalkyl, CN, NO2, OR12, SR12, C(O)R13, C(O)OR12, C(O)NR14R15, NR14R15, NR14CONHR15, NR14C(O)R13, NR14C(O)OR12, S(O)R13, S(O)2R13, S(O)NR14R15, SO2NR14R15;

    R7 is H, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, halo, C1-4 haloalkyl, OH, C1-4 alkoxy, C1-4 haloalkoxy, CN, NO2, C(O)—

    (C1-4 alkyl), C(O)OH, C(O)O—

    (C1-4 alkyl), C(O)NH2, C(O)NH(C1-4 alkyl), C(O)N(C1-4 alkyl)2, S(O)2NH2, S(O)2NH(C1-4 alkyl), S(O)2N(C1-4 alkyl)2, S(O)2

    (C1-4 alkyl), NH2, NH(C1-4 alkyl), or N(C1-4 alkyl)2;

    R8 is H, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, OH or C1-4 alkoxy;

    R9 is H, halo, C1-4 alkyl, C1-4 haloalkyl, C2-4 alkenyl, C2-4 alkynyl, OH, C1-4 alkoxy or C1-4 haloalkoxy;

    R10 and R11 are each, independently, H, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, cycloalkyl, arylalkyl, cycloalkylalkyl, CORa, SORa, or SO2Ra wherein each of said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, cycloalkyl, arylalkyl, or cycloalkylalkyl is optionally substituted by 1, 2 or 3 substitutents selected from halo, C1-4 alkyl, C1-4 haloalkyl, OH, C1-4 alkoxy, C1-4 haloalkoxy, amino, C1-4 alkylamino, C2-8 dialkylamino, aminocarbonyl, C1-4 alkylaminocarbonyl, or C2-8 dialkylaminocarbonyl, CN and NO2;

    or R10 and R11 together with the N atom to which they are attached form a heterocycloalkyl group optionally substituted by 1, 2 or 3 substitutents selected from halo, C1-4 alkyl, C1-4 haloalkyl, OH, C1-4 alkoxy, C1-4 haloalkoxy, amino, C1-4 alkylamino, C2-8 dialkylamino, aminocarbonyl, C1-4 alkylaminocarbonyl, or C2-8 dialkylaminocarbonyl;

    R12 and R13 are each, independently, H, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, cycloalkyl, arylalkyl, or cycloalkylalkyl;

    R14 and R15 are each, independently, H, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, cycloalkyl, arylalkyl, or cycloalkylalkyl;

    or R14 and R15 together with the N atom to which they are attached form a heterocyclyl group;

    Ra is H, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, cycloalkyl, arylalkyl, cycloalkylalkyl, heteroaryl, heterocycloalkyl, heteroarylalkyl, heterocycloalkylalkyl, NH2, NH(C1-6 alkyl), N(C1-6 alkyl)2, NH(carbocyclyl), N(carbocyclyl)2, NH(carbocyclylalkyl) or N(carbocyclylalkyl)2;

    with the proviso that when Ring A is;

    Ring B is;

    D1 is CR1a;

    D2 is N or CR1b D3 is CR1c; and

    D4 is CR1d;

    then W1 is O, S, NR11, SO, SO2, SONR11, SO2NR11, or NR11CONR12.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×